Immunoprotein Diagnostic Testing Market by Technology (Enzyme-Linked Immunoassay, Immunofluorescence Assay, Radioimmunoassay), Immunoprotein Type (C-reactive Protein, Complement System Protein, Immunoglobulin), Application, End-User - Global Forecast 2024

Immunoprotein Diagnostic Testing Market by Technology (Enzyme-Linked Immunoassay, Immunofluorescence Assay, Radioimmunoassay), Immunoprotein Type (C-reactive Protein, Complement System Protein, Immunoglobulin), Application, End-User - Global Forecast 2024-2030


The Immunoprotein Diagnostic Testing Market size was estimated at USD 8.81 billion in 2023 and expected to reach USD 9.41 billion in 2024, at a CAGR 6.92% to reach USD 14.07 billion by 2030.

Global Immunoprotein Diagnostic Testing Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Immunoprotein Diagnostic Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immunoprotein Diagnostic Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Immunoprotein Diagnostic Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, BioMérieux S.A., Calbiotech, Inc., Danaher Corporation, DiaSorin S.p.A., DiaSys Diagnostic Systems GmbH, Diazyme Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, Grifols, S.A., Luminex Corporation, Miraca Holdings Inc., Ortho Clinical Diagnostics, QIAGEN N.V., Randox Laboratories Ltd., SERVA Electrophoresis GmbH, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc., and Werfen.

Market Segmentation & Coverage

This research report categorizes the Immunoprotein Diagnostic Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology
Enzyme-Linked Immunoassay

Immunofluorescence Assay

Radioimmunoassay

Immunoprotein Type
C-reactive Protein

Complement System Protein

Immunoglobulin

Application
Allergy Testing

Autoimmune Disease Testing

Endocrine Testing

Infectious Disease Testing

Oncology Testing

Toxicology Testing

End-User
Diagnostic Laboratories

Hospitals & Clinics

Research Institutes

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Immunoprotein Diagnostic Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immunoprotein Diagnostic Testing Market?
3. What are the technology trends and regulatory frameworks in the Immunoprotein Diagnostic Testing Market?
4. What is the market share of the leading vendors in the Immunoprotein Diagnostic Testing Market?
5. Which modes and strategic moves are suitable for entering the Immunoprotein Diagnostic Testing Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Immunoprotein Diagnostic Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in incidence and prevalence of infectious and chronic diseases
5.1.1.2. Growth in demand for early diagnostic services in emerging economies
5.1.1.3. Rise in diagnostic tests and growing demand for chemiluminescence assay
5.1.2. Restraints
5.1.2.1. High cost of immunoprotein diagnostic tests
5.1.3. Opportunities
5.1.3.1. Technological advancements in immunodiagnostic instruments and the introduction of novel automated systems
5.1.3.2. Ongoing development in the condition-specific assays and tests
5.1.4. Challenges
5.1.4.1. Complex regulatory framework for the approval of immunoprotein diagnostic tests
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Immunoprotein Diagnostic Testing Market, by Technology
6.1. Introduction
6.2. Enzyme-Linked Immunoassay
6.3. Immunofluorescence Assay
6.4. Radioimmunoassay
7. Immunoprotein Diagnostic Testing Market, by Immunoprotein Type
7.1. Introduction
7.2. C-reactive Protein
7.3. Complement System Protein
7.4. Immunoglobulin
8. Immunoprotein Diagnostic Testing Market, by Application
8.1. Introduction
8.2. Allergy Testing
8.3. Autoimmune Disease Testing
8.4. Endocrine Testing
8.5. Infectious Disease Testing
8.6. Oncology Testing
8.7. Toxicology Testing
9. Immunoprotein Diagnostic Testing Market, by End-User
9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospitals & Clinics
9.4. Research Institutes
10. Americas Immunoprotein Diagnostic Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Immunoprotein Diagnostic Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.
10. South Korea
11.
11. Taiwan
11.
12. Thailand
11.
13. Vietnam
12. Europe, Middle East & Africa Immunoprotein Diagnostic Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.
10. Nigeria
12.
11. Norway
12.
12. Poland
12.
13. Qatar
12.
14. Russia
12.
15. Saudi Arabia
12.
16. South Africa
12.
17. Spain
12.
18. Sweden
12.
19. Switzerland
12.
20. Turkey
12.
21. United Arab Emirates
12.
22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Abcam PLC
14.1.3. Beckman Coulter Inc.
14.1.4. Becton, Dickinson and Company
14.1.5. Bio-Rad Laboratories Inc.
14.1.6. Bio-Techne Corporation
14.1.7. BioMérieux S.A.
14.1.8. Calbiotech, Inc.
14.1.9. Danaher Corporation
14.1.
10. DiaSorin S.p.A.
14.1.
11. DiaSys Diagnostic Systems GmbH
14.1.
12. Diazyme Laboratories Inc.
14.1.
13. Enzo Biochem Inc.
14.1.
14. F. Hoffmann-La Roche AG
14.1.
15. Grifols, S.A.
14.1.
16. Luminex Corporation
14.1.
17. Miraca Holdings Inc.
14.1.
18. Ortho Clinical Diagnostics
14.1.
19. QIAGEN N.V.
14.1.
20. Randox Laboratories Ltd.
14.1.
21. SERVA Electrophoresis GmbH
14.1.
22. Siemens Healthineers
14.1.
23. Sysmex Corporation
14.1.
24. Thermo Fisher Scientific Inc.
14.1.
25. Werfen
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET RESEARCH PROCESS
FIGURE 2. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET DYNAMICS
FIGURE 7. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2023 VS 2030 (%)
FIGURE 10. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings